reported that CD70/CD27 signaling promotes blast stemness, and blocking CD70/CD27 by mAb could prolong survival in murine AML xenografts, representing that CD70/CD27 is a promising therapeutic strategy for AML (149). This evidence concerns the gene CD70 and acute myeloid leukemia.